Candel Therapeutics, Inc.
(CADL - NASDAQ)
6,29 USD
📋 Profilo Aziendale

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients.

|